Literature DB >> 17899963

A study of antibiotics used in adult respiratory disorders in Kathmandu and Bhaktapur.

Serena Pradhan1, Akhilesh Chandra Jauhari.   

Abstract

Respiratory tract infections (RTI) are one of the major causes of morbidity and mortality, in Nepal, because of the climate, living conditions and economic status of the people. This study was done to find out the pattern of respiratory tract infections in adults and pattern of antibiotics (AB) prescribed in them and to explore the most economical treatment of patients without compromising the quality of it. Three hospitals of Kathmandu valley and two hospitals of Bhaktapur were selected. Out of 118 patients of RTI in which AB were prescribed, 110 patients were randomly selected in this study. Among them 53.6% were male and 46.4% were female, 43.7% patients were smokers and 56.3% were non-smokers. The average costs of treatment of upper respiratory tract infections (URTI) were lower then lower respiratory tract infections (LRTI). The cost of treatment of chronic respiratory cases was highest.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899963

Source DB:  PubMed          Journal:  Nepal Med Coll J


  3 in total

1.  Drug utilization pattern of antibacterials used in ear, nose and throat outpatient and inpatient departments of a university hospital at New Delhi, India.

Authors:  M R Ain; N Shahzad; M Aqil; M S Alam; R Khanam
Journal:  J Pharm Bioallied Sci       Date:  2010-01

2.  Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.

Authors:  Muhammad Miftahussurur; Pradeep Krishna Shrestha; Phawinee Subsomwong; Rabi Prakash Sharma; Yoshio Yamaoka
Journal:  BMC Microbiol       Date:  2016-11-04       Impact factor: 3.605

3.  Vitamin C as a Supplementary Therapy in Relieving Symptoms of the Common Cold: A Meta-Analysis of 10 Randomized Controlled Trials.

Authors:  Li Ran; Wenli Zhao; Hongwu Wang; Ye Zhao; Huaien Bu
Journal:  Biomed Res Int       Date:  2020-10-09       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.